The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 190.00
High: 190.00
Low: 190.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Jun 2022 07:00

RNS Number : 7089O
Synectics PLC
14 June 2022
 

 

 

RNS

 

14 June 2022

 

 

Synectics plc

("Synectics", the "Company" or the "Group")

 

Trading Update

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, provides the following trading update for the six months ended 31 May 2022 ("H1 2022").

Activity levels in the major end-user markets that Synectics serves generally continue to gather momentum, particularly in Oil & Gas and in US gaming. That recovery is as yet less evident in casinos and gaming resorts in Asia-Pacific where leisure travel has remained subdued. Although there are signs of increased customer activity in this region, firm business remains patchy and difficult to predict.

Trading in H1 2022 was in line with the Board's expectations and produced a considerable positive turnaround from the same period last year, with operating profits expected to be at a broadly similar level to the seasonally stronger second half of last year.

Operating profit for H1 2022 is estimated to be approximately £0.4 million (H1 2021: operating loss £(0.8) million) on revenues of approximately £23.0 million (H1 2021: £22.0 million). Net cash as at 31 May 2022 was approximately £3.9 million (31 May 2021: £3.5 million).

The improved results were largely driven by revenue growth of approximately 20 per cent in the Company's core Systems division as markets severely affected by the pandemic began their recovery. Although the division experienced some disruption to its supply chains from the prevalent global issues, proactive management meant that there was no material impact on delivery schedules or margins. The Systems division's gross margins in H1 2022 held up strongly, reflecting both its ability to pass on cost increases, and further progress in the Group's strategy of increased software content in its deliveries.

Good progress was made in H1 2022 on the Group's large projects for advanced infrastructure surveillance, including Deutsche Bahn in Berlin and the Cloud-based deployment of Synergy for the City of London Corporation and City of London Police. These continue to act as important reference sites for Synectics' core advanced technology.

In H1 2022, Synectics Security, the Group's UK-focused integration division, experienced a decline in revenues compared to the same period last year due principally to customer-led delays on several major projects that had been expected to be largely completed in the half. However, an improvement in the mix of business resulted in higher gross margins and an operating profit in H1 2022 expected to be at a similar level to the satisfactory result achieved in the same period last year.

Overall, the Board is pleased with Synectics' performance in H1 2022 and continues to expect further acceleration in the trajectory of improvement in the second half of the financial year.

Synectics will provide a further update on trading and announce its unaudited interim results for the six months ended 31 May 2022 on 12 July 2022.

 

Paul Webb, Chief Executive of Synectics, commented: "A strong team performance has meant we have been able to deliver our goals for this period despite increasing challenges in the supply chain and with markets still subdued. We have all been working through our 'return to work' challenges, and are in good shape now to push on together and deliver further improved results in the second half of this financial year and beyond"

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief ExecutiveDavid Bedford, Finance Director

email: info@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten

 

 Ends

 

About Synectics plc

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

Find out more at www.synecticsplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMVVFKGZZM
Date   Source Headline
24th Apr 202410:00 amRNSResult of AGM
24th Apr 20247:00 amRNSAGM Statement
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.